The Japanese Biochemical Society/The Molecular Biology Society of Japan

ConBio2017

ConBio2017

Dec 6, 2017 - Dec 9, 2017
Kobe Port Island(Kobe International Conference Center, Kobe Portopia Hotel, Kobe International Exhibition Hall, The Kobe Chamber of Commerce and Industry)

[2P-0855] Development of the combination therapy targeting ALK and p53 for neuroblastomas

〇Makoto Miyazaki1, Yuko Hibiya1, Hidenobu Suzuki1,2, Ayana Nakajima1,3, Naomi Abe1, Koichi Ichimura1, Arata Tomiyama1,4 (1.Div. Brain Tumor Translational Res., Natl. Cancer Ctr. Res. Inst., 2.NCC Cancer Sci., Tokyo Med. & Dent. Univ., 3.Grad. Sch. of Med. Life Sci. Yokohama City Univ., 4.Dept. Neurosurg. Natl. Def. Med. Col.)

ALK、Neuroblastoma、p53、transcriptional regulation、apoptosis

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password